Enhanced workflow for biomarker research
Thermo Fisher Scientific has acquired Intrinsic Bioprobes Inc., a manufacturer of immuno-enrichment, sample preparation tools used in quantitative mass spectrometry, with the intention of offering an enhanced solution for quantitative protein biomarker detection.
Thermo Fisher Scientific has acquired Intrinsic Bioprobes Inc., a manufacturer of immuno-enrichment, sample preparation tools used in quantitative mass spectrometry, with the intention of offering an enhanced solution for quantitative protein biomarker detection.
By adding Intrinsic Bioprobes’ mass spectrometric immunoassay (MSIA) technology to its portfolio, Thermo Fisher will be able to give researchers a complete, higher resolution view of the proteome as the technology allows enrichment of low-abundance proteins in biological samples providing greater specificity and sensitivity and offering clear advantages over ELISA and bead-based immunoassay formats.
“The Intrinsic Bioprobes’ portfolio will enhance Thermo Fisher’s position in the rapidly emerging field of clinical proteomics,” said Chuck Kummeth, president of Thermo Fisher’s laboratory consumables business. “It is a simple, yet powerful approach to uncovering the proteomic basis of disease, and it better positions us to support our customers in their efforts to realize the promise of personalized medicine.”
For further information visit ref="http://www.thermoscientific.com">www.thermoscientific.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
